相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Global prediction of primary liver cancer incidences and mortality in 2040
Chenxi Li et al.
JOURNAL OF HEPATOLOGY (2023)
PU.1 controls fibroblast polarization and tissue fibrosis
Thomas Wohlfahrt et al.
NATURE (2019)
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai et al.
CANCER CELL (2019)
Drug repurposing: progress, challenges and recommendations
Sudeep Pushpakom et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway
Li Luo et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Renoprotective effect of nifuroxazide in diabetes-induced nephropathy: impact on NFκB, oxidative stress, and apoptosis
Nehal M. Elsherbiny et al.
TOXICOLOGY MECHANISMS AND METHODS (2018)
Renoprotective effect of nifuroxazide in diabetes-induced nephropathy: impact on NFκB, oxidative stress, and apoptosis
Nehal M. Elsherbiny et al.
TOXICOLOGY MECHANISMS AND METHODS (2018)
Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
Hee-Young Yoon et al.
RESPIRATORY RESEARCH (2018)
The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Javier Milara et al.
RESPIRATORY RESEARCH (2018)
Macrophages: friend or foe in idiopathic pulmonary fibrosis?
Lei Zhang et al.
RESPIRATORY RESEARCH (2018)
Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway
Liu-Ya Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Nifuroxazide prompts antitumor immune response of TCL-loaded DC in mice with orthotopically-implanted hepatocarcinoma
Tiesuo Zhao et al.
ONCOLOGY REPORTS (2017)
Inhibition of Stat3 signaling pathway by nifuroxazide improves antitumor immunity and impairs colorectal carcinoma metastasis
Ting-Hong Ye et al.
CELL DEATH & DISEASE (2017)
Activation of STAT3 integrates common profibrotic pathways to promote fibroblast activation and tissue fibrosis
Debomita Chakraborty et al.
NATURE COMMUNICATIONS (2017)
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Kelly L. Walton et al.
FRONTIERS IN PHARMACOLOGY (2017)
Idiopathic pulmonary fibrosis
Fernando J. Martinez et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis
Isis E. Fernandez et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
What We Know About the Pathogenesis of Idiopathic Pulmonary Fibrosis
S. Puglisi et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Pulmonary Macrophages: A New Therapeutic Pathway in Fibrosing Lung Disease?
Adam J. Byrne et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials
Lisa Lancaster et al.
BMJ OPEN RESPIRATORY RESEARCH (2016)
Forced Vital Capacity in Idiopathic Pulmonary Fibrosis - FDA Review of Pirfenidone and Nintedanib
Banu A. Karimi-Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nifuroxazide induces apoptosis and impairs pulmonary metastasis in breast cancer model
F. Yang et al.
CELL DEATH & DISEASE (2015)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Rapamycin Inhibits Transforming Growth Factor β1-Induced Fibrogenesis in Primary Human Lung Fibroblasts
Yu Gao et al.
YONSEI MEDICAL JOURNAL (2013)
STAT3-Mediated Signaling Dysregulates Lung Fibroblast-Myofibroblast Activation and Differentiation in UIP/IPF
Dmitri V. Pechkovsky et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung
Outi Lepparanta et al.
CELL AND TISSUE RESEARCH (2012)
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
Brett Ley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Lynne A. Murray et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
STAT3 in tissue fibrosis: Is there a role in the lung?
Darryl Knight et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2011)
TGF-β-induced epithelial to mesenchymal transition
Jian Xu et al.
CELL RESEARCH (2009)
Targeting TLR2 Attenuates Pulmonary Inflammation and Fibrosis by Reversion of Suppressive Immune Microenvironment
Hong-Zhen Yang et al.
JOURNAL OF IMMUNOLOGY (2009)
Standardized quantification of pulmonary fibrosis in histological samples
Ralf-Harto Huebner et al.
BIOTECHNIQUES (2008)
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
Erik A. Nelson et al.
BLOOD (2008)
Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis
Haiying Yu et al.
FASEB JOURNAL (2008)
Inflammatory Cytokines Augments TGF-β1-Induced Epithelial-Mesenchymal Transition in A549 Cells by Up-Regulating TβR-I
Xiangde Liu
CELL MOTILITY AND THE CYTOSKELETON (2008)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease
Brigham C. Willis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Infectious disease, the innate immune response, and fibrosis
Alessia Meneghin et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia
Edwin Roger Parra et al.
RESPIRATION (2007)
Fibroblasts and myofibroblasts: Their source, function and role in disease
Robin J. McAnulty
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Stat3 contributes to keloid pathogenesis via promoting collagen production, cell proliferation and migration
C. P. Lim et al.
ONCOGENE (2006)
Smad3 null mice develop airspace enlargement and are resistant to TGF-β-mediated pulmonary fibrosis
P Bonniaud et al.
JOURNAL OF IMMUNOLOGY (2004)
Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment
N Khalil et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Cytokine regulation of pulmonary fibrosis in scleroderma
SP Atamas et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis
YD Xu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Pathogenesis of fibrosis:: role of TGF-β and CTGF
H Ihn
CURRENT OPINION IN RHEUMATOLOGY (2002)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)